Can hormone replacement therapy be used during medical therapy of endometriosis?

BJOG: An International Journal of Obstetrics & Gynaecology

Volumn 101, Issue , 1994, Pages 24-26

  Edmonds, D K ^a   Howell, R ^a  

^a QUEEN CHARLOTTE S AND CHELSEA HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; GOSERELIN; MEDROXYPROGESTERONE ACETATE;

ADULT; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; ENDOMETRIOSIS; FOLLOW UP; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SERUM; SUBCUTANEOUS DRUG ADMINISTRATION;

BONE DENSITY; ENDOMETRIOSIS; ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; FEMALE; GOSERELIN; HUMANS; MEDROXYPROGESTERONE 17-ACETATE; TREATMENT OUTCOME;

EID: 0028232355     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.1994.tb13681.x     Document Type: Article

References (12)

1. The treatment of endometriosis by inducing pseudopregnancy with ovarian hormones
2. Clinical studies with an antiandrogen—danazol
3. Treatment of endometriosis with antigonadotrophin — danazol
4. Management of pelvic endometriosis with low dose danazol
5. Danazol in the treatment of endometriosis
6. Is there a solution for recurrent endometriosis
7. Goserelin and the skeleton
8. Administration of nasal nafarelin as compared to oral danazol for endometriosis
9. Nafarelin in the treatment of pelvic pain caused by endometriosis
10. Nafarelin in endometriosis: a large scale danazol controlled trial of efficacy and safety with one year follow up
11. Dosage aspects of danazol therapy in endometriosis
12. The combination of a depot gonadotrophin releasing hormone agonist and cyclical hormone replacement therapy for dysfunctional uterine bleeding